Investing news

Latest investment headlines, research & analysis

Will Pfizer approach Viking Therapeutics with a buyout proposal?
Will Pfizer approach Viking Therapeutics with a buyout proposal?
  • Pfizer discontinues development of weight-loss pill due to a serious adverse effect.
  • Investors now expect it to acquire VKTX to expand in the anti-obesity market.
  • There are several reasons, however, why PFE may not go after Viking Therapeutics.
Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE: PFE) into terminating the development of its weight-loss pill. Viking’s share price has gained % in recent sessions on speculation that PFE will now resort to an acquisition to expand its footprint in the weight-loss […]
April 15, 2025

Trading ideas & analysis

Airbus stock price analysis: big beneficiary of Trump’s trade war
April 15, 2025
Sonic price analysis: ripe for a breakout as DeFi ecosystem grows
April 15, 2025
AppLovin stock price forecast: buy the dip or sell the rip?
April 15, 2025
Powell Industries stock price sends mixed signals: is it a good buy?
April 15, 2025

More breaking stories